Assessing the acceptability of, adherence to and preference for a dual prevention pill (DPP) for HIV and pregnancy prevention compared to oral pre-exposure prophylaxis (PrEP) and oral contraception taken separately: protocols for two randomised, controlled, cross-over studies in South Africa and Zimbabwe.

Autor: Friedland BA; Population Council, Center for Biomedical Research, New York, New York, USA Bfriedland@popcouncil.org., Mgodi NM; University of Zimbabwe - Clinical Trials Research Centre, Harare, Zimbabwe., Palanee-Phillips T; Wits Reproductive Health and HIV Institute, University of the Witwatersrand, Faculty of Health Sciences, School of Public Health, Johannesburg, South Africa.; University of Washington, Department of Epidemiology, School of Public Health, Seattle, Washington, USA., Mathur S; Population Council, Washington, District of Columbia, USA., Plagianos MG; Population Council, Center for Biomedical Research, New York, New York, USA., Bruce IV; Population Council, Center for Biomedical Research, New York, New York, USA., Lansiaux M; Population Council, Center for Biomedical Research, New York, New York, USA., Murombedzi C; University of Zimbabwe - Clinical Trials Research Centre, Harare, Zimbabwe., Musara P; University of Zimbabwe - Clinical Trials Research Centre, Harare, Zimbabwe., Dandadzi A; University of Zimbabwe - Clinical Trials Research Centre, Harare, Zimbabwe., Reddy K; Wits Reproductive Health and HIV Institute, University of the Witwatersrand, Faculty of Health Sciences, School of Public Health, Johannesburg, South Africa., Ndlovu N; Wits Reproductive Health and HIV Institute, University of the Witwatersrand, Faculty of Health Sciences, School of Public Health, Johannesburg, South Africa., Zulu SK; Wits Reproductive Health and HIV Institute, University of the Witwatersrand, Faculty of Health Sciences, School of Public Health, Johannesburg, South Africa., Shale LR; Wits Reproductive Health and HIV Institute, University of the Witwatersrand, Faculty of Health Sciences, School of Public Health, Johannesburg, South Africa., Zieman B; Population Council, Center for Biomedical Research, New York, New York, USA., Haddad LB; Population Council, Center for Biomedical Research, New York, New York, USA.

Publikováno v: BMJ open [BMJ Open] 2024 Mar 12; Vol. 14 (3), pp. e075381. Date of Electronic Publication: 2024 Mar 12.

Immunogenicity and safety following a homologous booster dose of a SARS-CoV-2 recombinant spike protein vaccine with Matrix-M ^TM adjuvant (NVX-CoV2373) versus a primary series in people living with and without HIV-1 infection in South Africa: A randomized crossover phase 2a/2b trial.

Autor: Shinde V; Research and Development, Novavax, Inc, Gaithersburg, MD, USA., Lombard Koen A; South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Hoosain Z; Research and Development, Josha Research Centre, Bloemfontein, Free State, South Africa., Archary M; Paediatric Infectious Diseases Unit, University of KwaZulu-Natal, Durban, South Africa., Bhorat Q; Research and Development, Soweto Clinical Trials Centre, Johannesburg, South Africa., Fairlie L; Wits RHI, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Lalloo U; Respiratory and Critical Care Unit, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa., Masilela MSL; Research and Development, Setshaba Research Centre, Tshwane, South Africa., Moodley D; Department of Obstetrics and Gynaecology, University of KwaZulu-Natal, Durban, South Africa., Hanley S; Centre for the AIDS Programme of Research in South Africa (CAPRISA), and Department of Family Medicine, University of KwaZulu-Natal, Durban, South Africa., Fouche LF; Research and Development, Limpopo Clinical Research Initiative, Thabazimbi, South Africa., Louw C; Research and Development, Madibeng Centre for Research, Brits, South Africa.; Faculty of Health Sciences, Department of Family Medicine, University of Pretoria, Pretoria, South Africa., Tameris M; South African TB Vaccine Initiative, University of Cape Town, Cape Town, South Africa., Singh N; South African Medical Research Council, HIV and other Infectious Diseases Research Unit (HIDRU) and, Health Systems Research Unit, Durban, South Africa., Goga A; South African Medical Research Council, HIV and other Infectious Diseases Research Unit (HIDRU) and, Health Systems Research Unit, Durban, South Africa., Dheda K; Centre for Lung Infection and Immunity, Division of Pulmonology, Department of Medicine and UCT Lung Institute, University of Cape Town, Cape Town, South Africa., Grobbelaar C; Aurum Institute, University of Pretoria, Pretoria, South Africa., Joseph N; Research and Development, PEERMED Clinical Trial Centre, Kempton Park, South Africa., Lombaard JJ; Research and Development, Josha Research Centre, Bloemfontein, Free State, South Africa., Mngqibisa R; Paediatric Infectious Diseases Unit, University of KwaZulu-Natal, Durban, South Africa., Bhorat AE; Research and Development, Soweto Clinical Trials Centre, Johannesburg, South Africa., Benadé G; Wits RHI, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Lalloo N; Respiratory and Critical Care Unit, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa., Pitsi A; Research and Development, Setshaba Research Centre, Tshwane, South Africa., Vollgraaff PL; Research and Development, Limpopo Clinical Research Initiative, Thabazimbi, South Africa., Luabeya A; South African TB Vaccine Initiative, University of Cape Town, Cape Town, South Africa., Esmail A; Centre for Lung Infection and Immunity, Division of Pulmonology, Department of Medicine and UCT Lung Institute, University of Cape Town, Cape Town, South Africa., Petrick FG; Research and Development, MERC Research, Middelburg, South Africa., Oommen Jose A; South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Foulkes S; Research and Development, Josha Research Centre, Bloemfontein, Free State, South Africa., Ahmed K; Research and Development, Setshaba Research Centre, Tshwane, South Africa.; Faculty of Health Sciences, Department of Microbiology, University of Pretoria, Pretoria, South Africa., Thombrayil A; South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Kalonji D; South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.; South African Medical Research Council, HIV and other Infectious Diseases Research Unit (HIDRU) and, Health Systems Research Unit, Durban, South Africa., Cloney-Clark S; Research and Development, Novavax, Inc, Gaithersburg, MD, USA., Zhu M; Research and Development, Novavax, Inc, Gaithersburg, MD, USA., Bennett C; Research and Development, Novavax, Inc, Gaithersburg, MD, USA., Albert G; Research and Development, Novavax, Inc, Gaithersburg, MD, USA., Marcheschi A; Research and Development, Novavax, Inc, Gaithersburg, MD, USA., Plested JS; Research and Development, Novavax, Inc, Gaithersburg, MD, USA., Neal S; Research and Development, Novavax, Inc, Gaithersburg, MD, USA., Chau G; Research and Development, Novavax, Inc, Gaithersburg, MD, USA., Cho I; Research and Development, Novavax, Inc, Gaithersburg, MD, USA., Fries L; Research and Development, Novavax, Inc, Gaithersburg, MD, USA., Glenn GM; Research and Development, Novavax, Inc, Gaithersburg, MD, USA., Madhi SA; South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Publikováno v: Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2425147. Date of Electronic Publication: 2024 Dec 12.

The Acute Ingestion of Yerba Mate (Ilex paraguariensis) Infusion Does Not Modify Endothelial Function, Hemodynamics, or Heart Rate Variability: A Randomized Crossover Clinical Trial.

Autor: Filipini RE; Department of Physiological Sciences, Biological Sciences Center, Federal University of Santa Catarina - Rua da Prefeitura Universitária, Córrego Grande, Florianópolis, SC, 88037-000, Brazil., José MFB; Department of Physiological Sciences, Biological Sciences Center, Federal University of Santa Catarina - Rua da Prefeitura Universitária, Córrego Grande, Florianópolis, SC, 88037-000, Brazil.; Multicenter Post-Graduate Program in Physiological Sciences, Federal University of Santa Catarina - Rua da Prefeitura Universitária, Córrego Grande, Florianópolis, SC, Brazil., Speretta GFF; Department of Physiological Sciences, Biological Sciences Center, Federal University of Santa Catarina - Rua da Prefeitura Universitária, Córrego Grande, Florianópolis, SC, 88037-000, Brazil. guilherme.speretta@ufsc.br.; Multicenter Post-Graduate Program in Physiological Sciences, Federal University of Santa Catarina - Rua da Prefeitura Universitária, Córrego Grande, Florianópolis, SC, Brazil. guilherme.speretta@ufsc.br.

Publikováno v: Plant foods for human nutrition (Dordrecht, Netherlands) [Plant Foods Hum Nutr] 2024 Dec 21; Vol. 80 (1), pp. 17. Date of Electronic Publication: 2024 Dec 21.

Effects of physical exercise on cardio-respiratory health of young adults during short-term exposure to varying air pollution levels.

Autor: Jin X; School of Exercise and Health, Shanghai University of Sport, Yangpu District Qingyuan Huan Road 650, Shanghai, 200438, China., Wang W; Sports Department, Baotou Medical College, Baotou, 014040, China., Sun Q; School of Exercise and Health, Shanghai University of Sport, Yangpu District Qingyuan Huan Road 650, Shanghai, 200438, China., Chen Y; School of Exercise and Health, Shanghai University of Sport, Yangpu District Qingyuan Huan Road 650, Shanghai, 200438, China., Xu B; School of Exercise and Health, Shanghai University of Sport, Yangpu District Qingyuan Huan Road 650, Shanghai, 200438, China. xubingxiang@sus.edu.cn.; Key Laboratory of Hebei Province for Molecular Biophysics, Institute of Biophysics, School of Health Science & Biomedical Engineering, Hebei University of Technology, Tianjin, 300130, China. xubingxiang@sus.edu.cn., Tian H; School of Exercise and Health, Shanghai University of Sport, Yangpu District Qingyuan Huan Road 650, Shanghai, 200438, China. tianhaili123@163.com.

Publikováno v: BMC public health [BMC Public Health] 2024 Dec 19; Vol. 24 (1), pp. 3543. Date of Electronic Publication: 2024 Dec 19.

Exogenous Glucagon-like Peptide 2 Counteracts Exogenous Cholecystokinin-induced Gallbladder Contraction in Healthy Men.

Autor: Lange AH; Center for Clinical Metabolic Research, Copenhagen University Hospital-Herlev and Gentofte, 2900 Hellerup, Denmark., Hansen NL; Center for Clinical Metabolic Research, Copenhagen University Hospital-Herlev and Gentofte, 2900 Hellerup, Denmark., Pedersen MG; Center for Clinical Metabolic Research, Copenhagen University Hospital-Herlev and Gentofte, 2900 Hellerup, Denmark., Nerild HH; Center for Clinical Metabolic Research, Copenhagen University Hospital-Herlev and Gentofte, 2900 Hellerup, Denmark., Rehfeld JF; Department of Clinical Biochemistry, Copenhagen University Hospital-Rigshospitalet, 2100 Copenhagen, Denmark., Hartmann B; Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark., Holst JJ; Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.; Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark., Ellegaard AM; Center for Clinical Metabolic Research, Copenhagen University Hospital-Herlev and Gentofte, 2900 Hellerup, Denmark., Knop FK; Center for Clinical Metabolic Research, Copenhagen University Hospital-Herlev and Gentofte, 2900 Hellerup, Denmark.; Clinical Research, Steno Diabetes Center Copenhagen, 2730 Herlev, Denmark.; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.

Publikováno v: The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2024 Dec 18; Vol. 110 (1), pp. 123-129.